FDA Investigator Luis A Solorzano
Luis A Solorzano has conducted inspections on 43 sites in 5 countries as of 24 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
43
Last Inspection Date:
24 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Peru,
Guatemala,
Spain,
Mexico
FDA Investigators that have inspected at least one site in common with Luis A Solorzano:
Abha R Bommireddi,
Adam S Freeman,
Alexis R Ajello,
Alison A Nicoli,
Andrew E Kay,
Andrew Tadros,
Angel K Sandhu,
Angela D Wise,
Anna J Vickrey,
Barbara J Arrais,
Breena L D'ambrogi,
Brian R Henderson,
Bruce D Broidy,
Capri R Woolridge,
Carol A Elems,
Chloe Anne Leong,
Christopher T Peters,
Cindy W Lewis,
Courtney R Bolton,
Cynthia L Ford,
Daniel C Geffin,
Darla R Bracy,
David G Eng,
David P King,
Debra C Yamane,
Edna J Hidalgo,
Emal Wahab,
Emmanuel O Kerry,
Estefania Fernandez,
Gale L Glinecki,
Gina M Hall,
Glen E Harelson,
Huy T Pham,
Ingrid A Zambrana,
James A Lane,
James C Yee,
Jane G Choi,
Janice Wai,
Jeanmaire Hryshko,
Jeanne A Young,
Jennifer A Hickey,
Jennifer Crumb,
Jennifer L Johnson,
Jenny K Yee,
Jeremy W Rotton,
Jocelyn T Ramos,
John A Liu,
John P Sanders, Jr,
Jolene S Hedgecock,
Jorge L Bertran,
Joseph Tibay,
Juan A Morales,
Juliane Kjung Lau,
Julio Salazar,
Kenneth Nieves,
Kimberly L Anderson,
Krystina M Jackson,
Larkin R Buckalew,
Lija V Fellows,
Linda S Shook,
Lorenzo F Edwards,
Lorraine N Williams,
Louis Christy,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Maridali Deleon Torres,
Marissa J Chan,
Mark I Nakano,
Mary C Acton,
Matthew K Wong,
Maximiano Perez,
Mcgrewp,
Michael C Nausin,
Michael T Macia,
Michelle L Lopez,
Michelle L Orner,
Nianna C Burns,
Nicole Yuen,
Nympha V Florendo,
Peter E Baker,
Phillip J Sample,
Phung,
Randall J Plunkett,
Randall P Zielinski,
Rebecca E Sulpacio,
Riley C Graham,
Roberta K Smith,
Roberto Macina,
Roger D Gawne,
Ronald P Boyce,
Sandra S Saniga,
Savannah E Samp,
Siobhan A Gallagher,
Steve P Yost,
Steven C Himebaugh,
Steven J Branch,
Stuart Kim,
Stuart W Russell,
Terrence Gee,
Thomas N Adjabeng,
Timothy C Grome,
Tomanik'e C Banks,
Travelle D Mason,
Victoria L Morgan,
Victoria Taylor,
Wayne L Jefferson,
Wendy S Shenk,
William J Weis,
William V Millar
Luis A Solorzano's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2005 | EIR | Country Home Products SA - EIR, 2005-09-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more